You are here

  • Home
  • Archive
  • Volume 67, Issue 5
  • Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy

Article metrics

Article menu
Download PDFPDF
Hepatology
Original article
Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy

 

Online download statistics by month:

Online download statistics by month: September 2017 to March 2024

AbstractFullPdf
Sep 201761311264
Oct 201748513996
Nov 201742911773
Dec 20172346742
Jan 20183027754
Feb 20182034836
Mar 20183055727
Apr 201867414882
May 201851913294
Jun 20184437035
Jul 20182837545
Aug 20182425839
Sep 20182915134
Oct 20182436843
Nov 20183105928
Dec 20183617946
Jan 20194528659
Feb 20193265628
Mar 20192524118
Apr 20192363121
May 20191041812
Jun 2019972111
Jul 2019165269
Aug 20191312614
Sep 20191714223
Oct 2019126218
Nov 20191322914
Dec 20191592811
Jan 2020136309
Feb 20201542311
Mar 2020162248
Apr 20201523014
May 20201793212
Jun 20202003124
Jul 20201421912
Aug 20201041510
Sep 20201782515
Oct 20202043837
Nov 20202034523
Dec 20201953727
Jan 20212423114
Feb 2021158199
Mar 20212554728
Apr 20211712413
May 2021833614
Jun 2021514824
Jul 2021372910
Aug 202138318
Sep 2021555018
Oct 20211753614
Nov 20211993215
Dec 2021205437
Jan 20221702410
Feb 2022292319
Mar 20224294912
Apr 2022279216
May 2022274289
Jun 2022275286
Jul 20222873110
Aug 2022494347
Sep 20222833510
Oct 20223594612
Nov 2022279379
Dec 2022326183
Jan 2023293388
Feb 2023255267
Mar 20232383311
Apr 2023296184
May 2023190235
Jun 2023159194
Jul 2023242337
Aug 2023311235
Sep 2023265292
Oct 20232892211
Nov 2023269248
Dec 2023283289
Jan 20243162517
Feb 2024278168
Mar 20242972518
Total1969433211669